{{Drugbox
| verifiedrevid = 447985201
| IUPAC_name = 2-morpholin-4-ylethyl 2-<nowiki/>{[3-(trifluoromethyl)phenyl]amino}nicotinate
| image = morniflumate.png

<!--Clinical data-->
| tradename =  
| Drugs.com = {{drugs.com|international|morniflumate}}
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B            / C / D / X -->
| pregnancy_category =  
| legal_AU = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 -->
| legal_CA = <!--             / Schedule I, II, III, IV, V, VI, VII, VIII -->
| legal_UK = <!-- GSL         / P       / POM / CD / Class A, B, C -->
| legal_US = <!-- OTC                   / Rx-only  / Schedule I, II, III, IV, V -->
| legal_status =  
| routes_of_administration =  

<!--Pharmacokinetic data-->
| bioavailability =  
| protein_bound =  
| metabolism =  
| elimination_half-life =  
| excretion =  

<!--Identifiers-->
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 65847-85-0
| ATC_prefix = M01
| ATC_suffix = AX22
| PubChem = 72106
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank =  
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 65089
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = R133MWH7X1
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D05078

<!--Chemical data-->
| C=19 | H=20 | F=3 | N=3 | O=3 
| molecular_weight = 395.37561 g/mol
| smiles = FC(F)(F)c1cc(ccc1)Nc2ncccc2C(=O)OCCN3CCOCC3
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C19H20F3N3O3/c20-19(21,22)14-3-1-4-15(13-14)24-17-16(5-2-6-23-17)18(26)28-12-9-25-7-10-27-11-8-25/h1-6,13H,7-12H2,(H,23,24)
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = LDXSPUSKBDTEKA-UHFFFAOYSA-N
}}

'''Morniflumate''' is a [[nonsteroidal anti-inflammatory drug]] (NSAID).<ref>{{Cite journal 
| last1 = Melica | first1 = A. 
| last2 = Donateo | first2 = L. 
| last3 = Gerardi | first3 = R. 
| last4 = Parenti | first4 = M. 
| title = A new anti-inflammatory-analgesic-antipyretic, morniflumate, in the treatment of chronic recurring bronchitis 
| journal = Rivista europea per le scienze mediche e farmacologiche = European review for medical and pharmacological sciences = Revue europeenne pour les sciences medicales et pharmacologiques 
| volume = 13 
| issue = 1–2 
| pages = 51–60 
| year = 1991 
| pmid = 1796197
}}</ref><ref>{{Cite journal 
| last1 = Civelli | first1 = M. 
| last2 = Vigano | first2 = T. 
| last3 = Acerbi | first3 = D. 
| last4 = Caruso | first4 = P. 
| last5 = Giossi | first5 = M. 
| last6 = Bongrani | first6 = S. 
| last7 = Folco | first7 = G. C. 
| title = Modulation of arachidonic acid metabolism by orally administered morniflumate in man 
| journal = Agents and actions 
| volume = 33 
| issue = 3–4 
| pages = 233–239 
| year = 1991 
| pmid = 1659152 | doi=10.1007/bf01986568
}}</ref><ref>{{Cite journal | last1 = Schiantarelli | first1 = P. | last2 = Cadel | first2 = S. | last3 = Acerbi | first3 = D. | doi = 10.1007/BF01966649 | title = A gastroprotective anti-inflammatory agent: Theβ-morpholinoethyl ester of niflumic acid (morniflumate) | journal = Agents and Actions | volume = 14 | issue = 2 | pages = 247–256 | year = 1984 | pmid =  6608862| pmc = }}</ref>

==References==
{{Reflist|2}}

{{Anti-inflammatory and antirheumatic products}}
{{Prostanoidergics}}

[[Category:Morpholines]]
[[Category:Nicotinates]]
[[Category:Trifluoromethyl compounds]]
[[Category:Anilines]]


{{musculoskeletal-drug-stub}}